Prestige Consumer Healthcare Inc. (PBH) is a publicly traded Healthcare sector company. As of November 5, 2026, PBH trades at $51.16 with a market cap of $2.35B and a P/E ratio of 12.90. PBH moved -3.99% today. Year to date, PBH is -14.74%; over the trailing twelve months it is -12.01%. Its 52-week range spans $42.62 to $89.37. Analyst consensus is buy with an average price target of $72.00. Rallies surfaces PBH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks PBH insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $51.16 |
| Market Cap | $2.35B |
| P/E Ratio | 12.90 |
| EPS | $3.58 |
| Dividend Yield | 0.31% |
| 52-Week High | $89.37 |
| 52-Week Low | $42.62 |
| Volume | 48 |
| Avg Volume | 0 |
| Revenue (TTM) | $1.10B |
| Net Income | $172.01M |
| Gross Margin | 53.53% |
2 analysts cover PBH: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $72.00.